Article
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes.
Virology journal - 2 Jul 2007
Bartlett Emmalene J, Castaño Adam, Surman Sonja R, Collins Peter L, Skiadopoulos Mario H, Murphy Brian R
Abstract excerpt
BACKGROUND: Two recombinant, live attenuated human parainfluenza virus type 1 (rHPIV1) mutant viruses have been developed, using a reverse genetics system, for evaluation as potential intranasal vaccine candidates. These rHPIV1 vaccine candidates have two non-temperature sensitive (non-ts) attenuating (att) mutations primarily in the P/C gene, namely CR84GHNT553A (two point mutations used together as a set) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
